Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation
| dc.contributor.author | MacDonald, Karen V. | |
| dc.contributor.author | Heidenreich, Sebastian | |
| dc.contributor.author | Krucien, Nicolas | |
| dc.contributor.author | Boycott, Kym M. | |
| dc.contributor.author | Bernier, Francois P. | |
| dc.contributor.author | Ryan, Mandy | |
| dc.contributor.author | Marshall, Deborah A. | |
| dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
| dc.date.accessioned | 2025-11-27T09:42:01Z | |
| dc.date.issued | 2025-11-12 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 925087 | |
| dc.identifier | 311132636 | |
| dc.identifier | 187e8c2e-eec2-4f43-9f5c-e1e88c0c34e7 | |
| dc.identifier | 105021534401 | |
| dc.identifier.citation | MacDonald, K V, Heidenreich, S, Krucien, N, Boycott, K M, Bernier, F P, Ryan, M & Marshall, D A 2025, 'Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation', European Journal of Health Economics. https://doi.org/10.1007/s10198-025-01870-8 | en |
| dc.identifier.doi | 10.1007/s10198-025-01870-8 | |
| dc.identifier.issn | 1618-7601 | |
| dc.identifier.other | RIS: urn:B9DBB36193C30CA3AAD60FB3246F53E0 | |
| dc.identifier.other | RIS: MacDonald2025 | |
| dc.identifier.uri | https://hdl.handle.net/2164/26477 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/105021534401 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Journal of Health Economics | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Next generation sequencing | en |
| dc.subject | Rare diseases | en |
| dc.subject | Patient preferences | en |
| dc.subject | User-based valuation | en |
| dc.subject | D61 (Allocative Efficiency, Cost-Benefit Analysis) | en |
| dc.subject | I18 (Government Policy, Regulation, Public Health) | en |
| dc.subject | I12 (Health Behavior) | en |
| dc.subject | I11 (Analysis of Health Care Markets) | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Economics, Econometrics and Finance (miscellaneous) | en |
| dc.subject | Health Policy | en |
| dc.subject.lcc | R1 | en |
| dc.title | Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- MacDonald_etal_EJHE_Is_Next_Generation_AAM.pdf
- Size:
- 903.41 KB
- Format:
- Adobe Portable Document Format
